Involvement of Phosphodiesterase Isozymes in Osteoblastic Differentiation
Open Access
- 1 February 2002
- journal article
- Published by Oxford University Press (OUP) in Journal of Bone and Mineral Research
- Vol. 17 (2) , 249-256
- https://doi.org/10.1359/jbmr.2002.17.2.249
Abstract
The cyclic monophosphate nucleotides (cyclic adenosine monophosphate [cAMP] and cyclic guanosine monophosphate [cGMP]) are found ubiquitously in mammalian cells and act as second messenger transducers to effect the intracellular actions of a variety of hormones, cytokines, and neurotransmitters. In turn, these nucleotides also modulate the signal transduction processes regulated by a range of cytokines and growth factors. Previously, we have reported that pentoxifylline, a nonselective phosphodiesterase (PDE) inhibitor, can promote osteoblastic differentiation by elevating intracellular cAMP levels and, consequently, enhance bone formation in vivo and in vitro. In this study, reverse-transcription polymerase chain reaction (RT-PCR) analysis of the osteoblastic cell lines, MC3T3-E1 and ST2 revealed the presence of PDE1, PDE2, PDE3, PDE4, PDE7, PDE8, and PDE9. We examined the effect of selective inhibitors for a respective PDE isozyme on the capacity of bone morphogenetic protein 4 (BMP-4)-induced alkaline phosphatase (ALP) activity, a cellular differentiation marker, in cells with osteogenetic potential. The results indicate that selective inhibitors for PDE2, PDE3, and PDE4 enhanced the BMP-4-induced ALP activity in a dose-dependent manner in ST2 cells but not in MC3T3-E1 cells. Northern blot analysis also revealed that the selective inhibitors for PDE2, PDE3, and PDE4 enhanced the levels of expression of messenger RNAs (mRNAs) of ALP, osteopontin (OP), and collagen type I in ST2 cells but not in MC3T3-E1 cells except for the treatment with PDE4 inhibitor. Given these data, we conclude that PDE isozymes are involved in the modulation of osteoblastic differentiation mainly at an early stage. Additionally, selective inhibitors for PDE2, PDE3, and PDE4 appear to promote the differentiation of osteogenic precursor cells toward an osteoblastic phenotype.Keywords
This publication has 41 references indexed in Scilit:
- Expression of the PEBP2αA/AML3/CBFA1 Gene is Regulated by BMP4/7 Heterodimer and Its Overexpression Suppresses Type I Collagen and Osteocalcin Gene Expression in Osteoblastic and Nonosteoblastic Mesenchymal CellsBone, 1998
- Interaction between Soluble Type I Receptor for Bone Morphogenetic Protein and Bone Morphogenetic Protein-4Published by Elsevier ,1997
- Rapid Protein Kinase A—Mediated Activation of Cyclic AMP-Phosphodiesterase by Parathyroid Hormone in UMR-106 Osteoblast-like CellsJournal of Bone and Mineral Research, 1997
- PTH: A future role in the management of osteoporosis?Journal of Bone and Mineral Research, 1996
- Effects of BMP-2, BMP-4, and BMP-6 on Osteoblastic Differentiation of Bone Marrow-Derived Stromal Cell Lines, ST2 and MC3T3-G2/PA6Biochemical and Biophysical Research Communications, 1996
- Signal transduction pathways mediating parathyroid hormone regulation of osteoblastic gene expressionJournal of Cellular Biochemistry, 1994
- Bone morphogenetic proteins (BMP-2 and BMP-3) promote growth and expression of the differentiated phenotype of rabbit chondrocytes and osteoblastic MC3T3-E1 cells in vitroJournal of Bone and Mineral Research, 1991
- Primary sequence of cyclic nucleotide phosphodiesterase isozymes and the design of selective inhibitorsTrends in Pharmacological Sciences, 1990
- The role of bone cells in increasing metaphyseal hard tissue in rapidly growing rats treated with prostaglandin E2Bone, 1987
- In vitro differentiation and calcification in a new clonal osteogenic cell line derived from newborn mouse calvaria.The Journal of cell biology, 1983